A

Avadel Pharmaceuticals-adr (AVDL)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Avadel Pharmaceuticals-adr (AVDL)

Avadel Pharmaceuticals plc is a biopharmaceutical company. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcole... Read more

  • 9.21
  • 9.21
  • 8.42
  • 10.02
  • 37.5%
  • --
  • 879.14k
  • 911.78k
  • 573M
  • 1.05
  • 8.9%
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.